Attributes | Values |
---|
rdf:type
| |
description
| - artículu científicu espublizáu en 1998 (ast)
- vědecký článek publikovaný v roce 1998 (cs)
- наукова стаття, опублікована в червні 1998 (uk)
- 1998 թվականի հունիսին հրատարակված գիտական հոդված (hy)
- 1998 թուականի Յունիսին հրատարակուած գիտական յօդուած (hyw)
- article publié dans la revue scientifique Journal of Biological Chemistry (fr)
- scientific journal article (en)
- im Juni 1998 veröffentlichter wissenschaftlicher Artikel (de)
- vedecký článok (publikovaný 1998/06/05) (sk)
- مقالة علمية (نشرت في 5-6-1998) (ar)
- wetenschappelijk artikel (gepubliceerd op 1998/06/05) (nl)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - J. A. Tischfield
- M. Murakami
- I. Kudo
- T. Kambe
- H. Kuwata
- M. V. Winstead
- S. Shimbara
|
rdfs:label
| - The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (en)
- The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (nl)
- The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (ast)
|
skos:prefLabel
| - The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (en)
- The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (nl)
- The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (ast)
|
name
| - The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (en)
- The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (nl)
- The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (ast)
|
title
| |
title
| - The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2 (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
ResearchGate publication ID
| |
ResearchGate publication ID
| |
is about
of | |
is cites work
of | - Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D
- Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes
- Cloning and characterization of novel mouse and human secretory phospholipase A(2)s
- Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s
- Neuroinflammation and synaptic loss
- Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids.
- Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells
- New developments in phospholipase A2.
- Mechanisms by which elevated intracellular calcium induces S49 cell membranes to become susceptible to the action of secretory phospholipase A2.
- Stimulation-dependent recruitment of cytosolic phospholipase A2-alpha to EA.hy.926 endothelial cell membranes leads to calcium-independent association
- Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis
- Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis
- Functional association of type IIA secretory phospholipase A(2) with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway
- Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways
- The expanding superfamily of phospholipase A(2) enzymes: classification and characterization
- Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D.
- Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition.
- Induction of ectopic olfactory structures and bone morphogenetic protein inhibition by Rossy, a group XII secreted phospholipase A2.
- Cellular arachidonate-releasing function of novel classes of secretory phospholipase A2s (groups III and XII).
- Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.
- Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms
- Phospholipases A2 in ischemic and toxic brain injury
- Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury
- Diversity and regulatory functions of mammalian secretory phospholipase A2s.
- Phospolipase A2 and apoptosis
- Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2.
- Regulation of type V phospholipase A2 expression and function by proinflammatory stimuli
- Cloning and recombinant expression of a novel mouse-secreted phospholipase A2.
- A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex
- Secretory phospholipase A2 activity in the normal and kainate injected rat brain, and inhibition by a peptide derived from python serum
- Phospholipase A2 enzymes
- Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha
- Cross-talk between group IIA-phospholipase A2 and inducible NO-synthase in rat renal mesangial cells
- Fcgamma RI-triggered generation of arachidonic acid and eicosanoids requires iPLA2 but not cPLA2 in human monocytic cells
- Highly selective hydrolysis of fatty acyl-CoAs by calcium-independent phospholipase A2beta. Enzyme autoacylation and acyl-CoA-mediated reversal of calmodulin inhibition of phospholipase A2 activity
- Brain lipid metabolism in the cPLA2 knockout mouse
- Role of phospholipase A2 activation and calcium in CYP2E1-dependent toxicity in HepG2 cells
- Dopamine D(2) receptor-induced COX-2-mediated production of prostaglandin E(2) in D(2)-transfected Chinese hamster ovary cells without simultaneous administration of a Ca(2+)-mobilizing agent
- Low molecular weight group IIA and group V phospholipase A(2) enzymes have different intracellular locations in mouse bone marrow-derived mast cells
- The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.
|